This is the authors' abstract. We don't add key points for this paper.
Glycoproteins, which are recognized by specific receptors on the sinusoidal surfaces of liver parenchymal and nonparenchymal cells, were radiolabeled by a methylation procedure that incorporated 75-90% of [3HJmethyl groups into lysine residues.Upon receptormediated endocytosis, the methylated glycoproteins were degraded and the methylated lysine residues released.The fate and metabolism of mono-, di-, and trimethyllysine residues released from the degradation of the methylated derivatives of asialo-fetuin and asido-orosomucoid (ASOR) within liver cells was examined and compared to the results obtained with similarly methylated agalacto-orosomucoid (AGOR).No significant production of carnitine or its precursors was evident from the dimethylated derivatives of these glycoproteins.Instead, significant amounts of the 3H label were recovered as 3H20 or as C3H]dimethyllysine.However, when the trimethylated derivatives Lys-(Me3)-asialo-fetuin, Lys(Me3)-ASOR, and Lys(MeJj-AGOR were degraded in the course of perfusion through an isolated rat liver, the trimethyllysine released was efficiently metabolized to 4-N-trimethylaminobutyrate, carnitine, and acetylcarnitine.Carnitine formation from Lys(Me3)-asialo-fetuin, Lys(Me3)-ASOR, and Lys(Mes)-AGOR was 1 2 4 , 69%, and 28%, respectively, within 4 h after the addition of the glycoprotein to the perfusion medium.Parenchymal cells, considered to specifically metabolize the administered Lys(Me3)-asialo-fetuin and Lys(Me+ASOR, were able to modify 15-20% of the injected Lys(Me3) by acetylation of the a-amino group.During degradation of these glycoproteins an accumulation of hepatic Lys(Me3) was seen to reach 35% at 60 min; over the next 4 h, Lys(Mea) levels within the liver decreased to 2-595.When the source of Lys(Me3) was Lys(Mes)-AGOR, known to be metabolized by nonparenchymal cells, the major radioactive component of the liver was 4-N-trimethylaminobutyrate (20% of the AGOR-bound Lys(Meo) injected).Conversely, no significant accumulation of 4-N-trimethylaminobutyrate was evident in the livers perfused with either Lys(Me3)-asialo-fetuin or Lys(Me3-ASOR.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dunn et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: